| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▲ | 1.58▲ | 1.60▲ | 1.56▲ | 1.36▲ |
| MA10 | 1.57▲ | 1.59▲ | 1.61▲ | 1.36▲ | 1.58▲ |
| MA20 | 1.57▲ | 1.61▲ | 1.58▲ | 1.34▲ | 2.57▼ |
| MA50 | 1.59▲ | 1.55▲ | 1.38▲ | 1.66▼ | 5.11▼ |
| MA100 | 1.61▲ | 1.36▲ | 1.31▲ | 2.73▼ | 12.59▼ |
| MA200 | 1.57▲ | 1.31▲ | 1.43▲ | 4.84▼ | 24.80▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.009▼ | -0.015▼ | 0.080▲ | 0.040▲ |
| RSI | 68.053▲ | 56.757▲ | 59.208▲ | 56.356▲ | 36.957▼ |
| STOCH | 38.889 | 36.076 | 36.519 | 79.284 | 11.537▼ |
| WILL %R | 0.000▲ | -44.444 | -34.884 | -12.903▲ | -73.267 |
| CCI | 308.037▲ | -0.645 | -12.082 | 123.293▲ | -50.064 |
|
Monday, January 05, 2026 05:17 AM
ALT5 Sigma Corporation (the "Company" or "ALT5") (NASDAQ: ALTS) (FRA: 5AR1), a fintech company operating institutional-grade global payments, trading, and settlement infrastructure, today announced ...
|
|
Monday, January 05, 2026 04:45 AM
Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...
|
|
Tuesday, December 02, 2025 08:01 AM
LAS VEGAS--(BUSINESS WIRE)--ALT 5 Sigma Corporation (the “Company” or “ALT5”) (NASDAQ: ALTS)(FRA: 5AR1) today announced that it received a notification letter (the “Letter”) from the Nasdaq Stock ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/01/26 | 1.64 | 1.67 | 1.545 | 1.62 | 2,882,917 |
| 08/01/26 | 1.48 | 1.70 | 1.475 | 1.68 | 5,736,442 |
| 07/01/26 | 1.53 | 1.54 | 1.42 | 1.46 | 2,594,000 |
| 06/01/26 | 1.45 | 1.615 | 1.45 | 1.54 | 5,783,936 |
| 05/01/26 | 1.29 | 1.55 | 1.29 | 1.51 | 8,181,193 |
| 02/01/26 | 1.13 | 1.22 | 1.12 | 1.21 | 3,850,985 |
| 31/12/25 | 1.10 | 1.17 | 1.08 | 1.10 | 2,967,500 |
| 30/12/25 | 1.17 | 1.205 | 1.09 | 1.12 | 5,451,250 |
| 29/12/25 | 1.16 | 1.26 | 1.16 | 1.18 | 2,921,151 |
| 26/12/25 | 1.18 | 1.21 | 1.14 | 1.18 | 1,872,267 |
|
|
||||
|
|
||||
|
|